|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges显示文摘Arrhythmogenic right ventricular cardiomyopathy(ARVC) is a genetic disease characterized by myocyte loss and fibro-fatty tissue replacement. Diagnosis of ARVC remains a clinical challenge mainly at its early stages and in patients with minimal echocardiographic right ventricular(RV) abnormalities. ARVC shares some common features with other cardiac diseases, such as RV outflow ventricular tachycardia, Brugada syndrome, and myocarditis, due to arrhythmic expressivity and biventricular involvement. The identification of ARVC can be often challenging, because of the heterogeneous clinical presentation, highly variable intra- and inter-family expressivity and incomplete penetrance. This genotypephenotype 'plasticity' is largely unexplained. A familial history of ARVC is present in 30% to 50% of cases, and the disease is considered a genetic cardiomyopathy, usually inherited in an autosomal dominant pattern with variable penetrance and expressivity; in addition, autosomal recessive forms have been reported(Naxos disease and Carvajal syndrome). Diagnosis of ARVC relays on a scoring system, with major or minorcriteria on the Revised Task Force Criteria. Implantable cardioverter defibrillators(ICDs) are increasingly utilized in patients with ARVC who have survived sudden death(SD)(secondary prevention). However, there are few data available to help identifying ARVC patients in whom the prophylactic implantation of an ICD is truly warranted. Prevention of SD is the primary goal of management. Pharmacologic treatment of arrhythmias, catheter ablation of ventricular tachycardia, and ICD are the mainstay of treatment of ARVC. | Bruno Pinamonti Francesca Brun Luisa Mestroni Gianfranco Sinagra | 2014 | World Journal of Cardiology2014，6，12： | 3 |
| 2 | Familial dilated cardiomyopathy 显示文摘 | Mestroni L Krajinovic M Severini GM | 1994 | Br Heart J1994，72，： | 1 |
| 3 | Asymmetric hydrogen transfer reactions promoted by homogeneous transition metal catalysts显示文摘 | Zassinovich G Mestroni G | 1992 | Chemical Review1992，92，： | 1 |
| 4 | Cardiomy- opathy and camitine deficiency 显示文摘 | Amat di San Filippo C Taylor MR Mestroni L | 2008 | Mol Genet Metab2008，94，2： | 1 |
| 5 | Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples 显示文摘 | Severini GM Mestroni L Falaschi A | 1993 | J Clin Microbiol1993，31，5： | 1 |
| 6 | Bridg- ing properties of disulfoxide ligands: Crystal structure of copper( 1,3 - bis ( n - propylsulfinyl ) propane ) perchlo- rate显示文摘 | GEREMIA S CALLIGARIS M MESTRONI S | 1999 | Inorg Chim Acta1999，292，： | 1 |
| 7 | Geneticevaluation of cardiomyopathy-a Heart Failure Society of Americapractice guideline显示文摘 | Hershberger RE Lindenfeld J Mestroni L | 2009 | J Card Fail2009，15，： | 1 |
| 8 | Sudden death associated with Danon disease in women显示文摘 | Miani D Taylor M Mestroni L | 2012 | Am J Cardiol2012，109，3： | 1 |
| 9 | Genetic evaluation of eardiomyopathy-a Heart Failure Soeiety of America practice guideline显示文摘 | Hershberger RE Lindenfeld J Mestroni L | 2009 | J Card Fail2009，15，2： | 1 |
| 10 | Caspofungin as first line therapy of pulmonary invasive fungal infections in32im-munocompromised patients with hematologic malignancies显示文摘 | Candoni A Mestroni R Damiani D | 2005 | Eur J Haematol2005，75，3： | 1 |
| 11 | Asymmetric Hydrogen Transfer Reactions Promoted by Homogenous Transition Metal Catalysts显示文摘 | Zassinovich G Mestroni G | 1992 | Chem Rev1992，92，5： | 1 |
| 12 | Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies 显示文摘 | Candoni A Mestroni R Darniani D | 2005 | Eur J Haematol2005，75，： | 1 |
| 13 | Catalytic reductive carbonylation of aromatic nitro compounds to urethanes promoted by supported palladium activated with 1,10-phenanthroline derivatives 显示文摘 | Enzo Alessio Giovanni Mestroni | 1985 | J Organometallic Chem1985，291，1： | 1 |
| 14 | Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples显示文摘 | SEVERINI G M MESTRONI L FALASCHI A | 1993 | J Clin Micorobiol1993，31，5： | 1 |
| 15 | LaminA/C gene and the heart:how genet- ics may impact clinical care 显示文摘 | Mestroni L Taylor MR | 2008 | J Am Coil Cardiol2008，52，15： | 1 |
| 16 | Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies 显示文摘 | Candoni A Mestroni R Damiani D | 2005 | Eur J Haernatol2005，75，3： | 1 |
| 17 | Cardiomyopathy and carnitine deficiency显示文摘 | Amat DS Taylor MR Mestroni L | 2008 | Mol Genet Metab2008，94，： | 1 |
| 18 | Genomic medicine and atrial fibrillation显示文摘 | Mestroni L | 2003 | J Am Coll Cardiol2003，41，： | 1 |
| 19 | Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies 显示文摘 | Candoni A Mestroni R Damiani D | 2005 | Eur J Haematol2005，75，3： | 1 |
| 20 | Femilial dilated cardiomyopathy:evidence for genetic and phenotypic hetorogeneity显示文摘 | Mestroni L Rocco C Gregori D | 1999 | J Am Coll Cardiol1999，34，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员